Application of Artificial Intelligence in Cardio-Oncology Imaging for Cancer Therapy–Related Cardiovascular Toxicity: Systematic Review
Einsatz von Artificial Intelligence in der Kardio-Onkologie-Bildgebung bei krebstherapiebedingter kardiovaskulärer Toxizität: systematische Übersicht
JMIR Cancer · 09.05.2025 · 11 · e63964-e63964
DOI: 10.2196/63964 ↗Auf einen Blick
7 Studien zeigen das Potenzial von AI zur Verbesserung der Kardio-Onkologie-Bildgebung bei der Vorhersage von Kardiotoxizität bei Krebspatient:innen.
Fragestellung
Welche Evidenz gibt es zum Einsatz von AI in der Kardio-Onkologie-Bildgebung zur Vorhersage von Kardiotoxizität?
Methode
Systematische Übersicht; Suche in PubMed, Ovid MEDLINE, Cochrane Library, CINAHL und Google Scholar von Beginn bis 2023; Originalstudien bei erwachsenen Krebspatient:innen mit Kardiotoxizitätsbewertung.
Ergebnisse
Eingeschlossen wurden 7 Studien (2018–2023). 71 % der Studien stammten aus den USA, 86 % betrafen Brustkrebs, 57 % nutzten MRT. Die Qualitätsbewertung ergab im Mittel 86 % Übereinstimmung.
Einschränkungen
Weitere Forschung mit größeren, multizentrischen Studien ist nötig, um die Anwendungen zu validieren und AI für den Routineeinsatz zu verfeinern.
Schlussfolgerung der Autor:innen
Die Autoren berichten, dass AI die Genauigkeit und Effizienz von Kardiotoxizitätsbeurteilungen verbessern kann.
Kernaussagen
- 7 Studien zur AI in der Kardio-Onkologie-Bildgebung
- Meist Brustkrebs (86 %) und MRT als Bildgebung (57 %)
- Weitere Validierung in größeren, multizentrischen Studien nötig
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift JMIR Cancer, online erschienen am 09.05.2025. Verfasst von Hayat Mushcab und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Office, Johns Hopkins Aramco Healthcare, Medical Access Road 1, Dhahran, Saudi Arabia, 966 556373411. Hauptthemen laut MEDLINE: Artificial Intelligence, Cardiotoxicity, Neoplasms, Cardiovascular Diseases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Artificial intelligence (AI) is a revolutionary tool yet to be fully integrated into several health care sectors, including medical imaging. AI can transform how medical imaging is conducted and interpreted, especially in cardio-oncology.
Objective
This study aims to systematically review the available literature on the use of AI in cardio-oncology imaging to predict cardiotoxicity and describe the possible improvement of different imaging modalities that can be achieved if AI is successfully deployed to routine practice.
Methods
We conducted a database search in PubMed, Ovid MEDLINE, Cochrane Library, CINAHL, and Google Scholar from inception to 2023 using the AI research assistant tool (Elicit) to search for original studies reporting AI outcomes in adult patients diagnosed with any cancer and undergoing cardiotoxicity assessment. Outcomes included incidence of cardiotoxicity, left ventricular ejection fraction, risk factors associated with cardiotoxicity, heart failure, myocardial dysfunction, signs of cancer therapy–related cardiovascular toxicity, echocardiography, and cardiac magnetic resonance imaging. Descriptive information about each study was recorded, including imaging technique, AI model, outcomes, and limitations.
Results
The systematic search resulted in 7 studies conducted between 2018 and 2023, which are included in this review. Most of these studies were conducted in the United States (71%), included patients with breast cancer (86%), and used magnetic resonance imaging as the imaging modality (57%). The quality assessment of the studies had an average of 86% compliance in all of the tool’s sections. In conclusion, this systematic review demonstrates the potential of AI to enhance cardio-oncology imaging for predicting cardiotoxicity in patients with cancer.
Conclusions
Our findings suggest that AI can enhance the accuracy and efficiency of cardiotoxicity assessments. However, further research through larger, multicenter trials is needed to validate these applications and refine AI technologies for routine use, paving the way for improved patient outcomes in cancer survivors at risk of cardiotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Office, Johns Hopkins Aramco Healthcare, Medical Access Road 1, Dhahran, Saudi Arabia, 966 556373411.
- College of Medicine, University College Dublin, Dublin, Ireland.
- College of Medicine, Royal College of Surgeons in Ireland-Bahrain, Muharraq, Bahrain.
- Emergency Department, King Fahad Medical City, Riyadh, Saudi Arabia.
- Health Informatics Department, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
- College of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
ORCID-Profile: Hayat Mushcab, Mohammed Al Ramis, Abdulrahman AlRujaib, Rawan Eskandarani, Tamara Sunbul, Anwar AlOtaibi, Mohammed Obaidan, Reman Al Harbi, Duaa Aljabri
Zitieren
APA
Mushcab, H., Al Ramis, M., AlRujaib, A., Eskandarani, R., Sunbul, T., AlOtaibi, A., Obaidan, M., Al Harbi, R., & Aljabri, D. (2025). Application of Artificial Intelligence in Cardio-Oncology Imaging for Cancer Therapy–Related Cardiovascular Toxicity: Systematic Review. JMIR Cancer, 11, e63964-e63964. https://doi.org/10.2196/63964
Vancouver
Mushcab H, Al Ramis M, AlRujaib A, Eskandarani R, Sunbul T, AlOtaibi A, et al. Application of Artificial Intelligence in Cardio-Oncology Imaging for Cancer Therapy–Related Cardiovascular Toxicity: Systematic Review. JMIR Cancer. 2025;11:e63964-e63964. doi:10.2196/63964
BibTeX
@article{Mushcab2025,
author = {Mushcab, Hayat and Al Ramis, Mohammed and AlRujaib, Abdulrahman and Eskandarani, Rawan and Sunbul, Tamara and AlOtaibi, Anwar and Obaidan, Mohammed and Al Harbi, Reman and Aljabri, Duaa},
title = {Application of Artificial Intelligence in Cardio-Oncology Imaging for Cancer Therapy–Related Cardiovascular Toxicity: Systematic Review},
journal = {JMIR Cancer},
year = {2025},
volume = {11},
pages = {e63964--e63964},
doi = {10.2196/63964}
}
EUVIMED